Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-12-12 | Amended | $3,862,000 | $25,000 | Debt Only | 06b | SEC link |
| 2024-09-06 | Amended | $3,837,000 | $1,475,000 | Debt Only | 06b | SEC link |
| 2022-08-19 | New | $2,362,000 | $2,362,000 | Debt Only | 06b | SEC link |
| 2020-12-15 | New | $7,172,432 | $7,172,432 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Christopher Belnap | Director, Executive |
| Eric Eason | Director |
| Rachelle Galvin | Director, Executive |
| Drew Lanza | Director |
| John Peryam | Director |
| Greg Werner | Director, Executive |